IMV (IMVIF) Shiller PE Ratio: (As of Sep. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IMVIF IMV Inc IMVIF
12 GF Score
Price $0.00
View Full Analysis

What is IMV Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


IMV  (OTCPK:IMVIF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


IMV Shiller PE Ratio Related Terms


IMV Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for IMV's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMV Shiller PE Ratio Chart

IMV Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IMV Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IMVIF vs RGTPQ, QBIO, RGIN: Shiller PE Ratio Comparison

For the Biotechnology subindustry, IMV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMV Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IMV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where IMV's Shiller PE Ratio falls into.


IMVIF
12GF Score
IMV Inc IMVIF
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IMV Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

IMV's E10 for the quarter that ended in Dec. 2022 is calculated as:

For example, IMV's adjusted earnings per share data for the three months ended in Dec. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2022 (Change)*Current CPI (Dec. 2022)
=-0.95/120.9639*120.9639
=-0.950

Current CPI (Dec. 2022) = 120.9639.

IMV Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201303 -0.629 97.103 -0.784
201306 -0.304 97.182 -0.378
201309 -0.620 97.419 -0.770
201312 -0.243 96.945 -0.303
201403 -0.579 98.604 -0.710
201406 -0.600 99.473 -0.730
201409 -0.573 99.394 -0.697
201412 -0.485 98.367 -0.596
201503 -0.505 99.789 -0.612
201506 -0.773 100.500 -0.930
201509 -0.477 100.421 -0.575
201512 -0.637 99.947 -0.771
201603 -0.493 101.054 -0.590
201606 -0.247 102.002 -0.293
201609 -0.487 101.765 -0.579
201612 -0.926 101.449 -1.104
201703 -1.440 102.634 -1.697
201706 -0.538 103.029 -0.632
201709 -0.403 103.345 -0.472
201712 -0.934 103.345 -1.093
201803 -0.542 105.004 -0.624
201806 -0.912 105.557 -1.045
201809 -1.084 105.636 -1.241
201812 -1.117 105.399 -1.282
201903 -0.974 106.979 -1.101
201906 -0.762 107.690 -0.856
201909 -1.209 107.611 -1.359
201912 -1.340 107.769 -1.504
202003 -1.400 107.927 -1.569
202006 -0.800 108.401 -0.893
202009 -0.800 108.164 -0.895
202012 -0.880 108.559 -0.981
202103 -1.000 110.298 -1.097
202106 -1.100 111.720 -1.191
202109 -1.300 112.905 -1.393
202112 -1.430 113.774 -1.520
202203 -1.300 117.646 -1.337
202206 -1.200 120.806 -1.202
202209 -1.100 120.648 -1.103
202212 -0.950 120.964 -0.950

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IMV Business Description

Address 130 Eileen Stubbs Avenue, Suite 19, Dartmouth, NS, CAN, B3B 2C4
IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.
12GF Score

Get the complete analysis for IMVIF

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price